Major Challenges Ahead for FDA and Pharma

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2022年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [1] Major Challenges Ahead for FDA and Pharma
    Wechsler, Jill
    [J]. Pharmaceutical Technology, 2022, 46 (01) : 13 - 18
  • [2] Major changes ahead for FDA
    Wechsler, J
    [J]. BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2002, 15 (11): : 50 - +
  • [3] COPYRIGHT - MAJOR CHALLENGES AHEAD
    MARSHALL, N
    [J]. WILSON LIBRARY BULLETIN, 1983, 57 (06) : 481 - 484
  • [4] Pandemic and Politics Shaped Pharma and FDA in 2022 Health crises, political tension, and budget concerns were major challenges
    Wechsler, Jill
    [J]. BIOPHARM INTERNATIONAL, 2022, 35 (12) : 8 - 9
  • [5] Are there blue skies ahead for ImClone systems? - Pharma company resubmits erbitux to FDA for approval
    Flanagan, N
    [J]. GENETIC ENGINEERING NEWS, 2003, 23 (20): : 55 - +
  • [6] MAJOR REGULATORY CHALLENGES CONFRONTING THE FDA
    HAYES, AH
    [J]. FOOD AND DRUG LAW JOURNAL, 1981, 36 (11): : 565 - 572
  • [7] Major challenges ahead for Hungarian healthcare
    Gaal, Peter
    Szigeti, Szabolcs
    Panteli, Dimitra
    Gaskins, Matthew
    van Ginneken, Ewout
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343 : 1251 - 1254
  • [8] MAJOR TRAUMA IN THE OLDER PERSON - MAJOR CHALLENGES AHEAD
    Doyle, Rachael
    Brent, Louise
    Connolly, Aisling
    Breslin, Tomas
    Jones, Sophie
    Kelly, Fionnola
    Lawrence, Tom
    Deasy, Conor
    [J]. AGE AND AGEING, 2019, 48
  • [9] New FDA commissioner faces major challenges
    Wechsler, J
    [J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (01): : 15 - +
  • [10] New FDA commissioner faces major challenges
    Wechsler, J
    [J]. FORMULARY, 2002, 37 (11) : 598 - 599
12345